This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Yasuyuki Okabe: Innovator in Somatostatin Receptor Agonists
Introduction
Yasuyuki Okabe is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target somatostatin receptors. His work is crucial for advancing treatments for various somatostatin-related diseases.
Latest Patents
Yasuyuki Okabe holds a patent for a compound having somatostatin receptor agonistic activity and its pharmaceutical use. The invention provides a somatostatin receptor subtype 2 agonist, represented by a specific general formula. This low-molecular compound exhibits strong agonistic activity, allowing for simple administration, high stability, and low toxicity. It is particularly useful for the prophylaxis and therapy of conditions such as acromegaly and gastrointestinal obstruction.
Career Highlights
Yasuyuki Okabe is associated with Ono Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His innovative approach has led to advancements in pharmaceutical applications, enhancing treatment options for patients.
Collaborations
He has collaborated with notable colleagues, including Akiharu Ishida and Takeshi Matsushita, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yasuyuki Okabe's work in developing somatostatin receptor agonists represents a significant advancement in pharmaceutical science. His contributions are vital for improving therapeutic strategies for somatostatin-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile